Drug Shortage Report for NALOXONE HCL INJECTION - 0.4MG/ML USP
Report ID | 80570 |
Drug Identification Number | 02148706 |
Brand name | NALOXONE HCL INJECTION - 0.4MG/ML USP |
Common or Proper name | NALOXONE HCl Inj |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | NALOXONE HYDROCHLORIDE |
Strength(s) | 0.4MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 1X10ml |
ATC code | V03AB |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-04-05 |
Estimated end date | 2019-07-08 |
Actual end date | 2019-06-19 |
Shortage status | Resolved |
Updated date | 2019-07-08 |
Company comments | Limited inventory is currently available for this product at Sandoz. To maintain our inventory levels and to avoid unanticipated bulk orders, the product will be placed on protective allocation at 150% of historical monthly volumes until return date. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2019-07-08 | French | Compare |
v11 | 2019-07-08 | English | Compare |
v10 | 2019-06-12 | French | Compare |
v9 | 2019-06-12 | English | Compare |
v8 | 2019-04-12 | English | Compare |
v7 | 2019-04-12 | French | Compare |
v6 | 2019-04-12 | English | Compare |
v5 | 2019-04-11 | French | Compare |
v4 | 2019-04-11 | English | Compare |
v3 | 2019-04-06 | English | Compare |
v2 | 2019-04-05 | French | Compare |
v1 | 2019-04-05 | English | Compare |
Showing 1 to 12 of 12